دورية أكاديمية
أعرض في EDS

Age-time-specific transmission of hand-foot-and-mouth disease enterovirus serotypes in Vietnam: A catalytic model with maternal immunity.

التفاصيل البيبلوغرافية
العنوان: Age-time-specific transmission of hand-foot-and-mouth disease enterovirus serotypes in Vietnam: A catalytic model with maternal immunity.
المؤلفون: Chen Y; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore. Electronic address: yining.chen@u.nus.edu., Nguyet LA; Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam., Nhan LNT; Children's Hospital 1, Ho Chi Minh City, Viet Nam., Qui PT; Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam., Nhu LNT; Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam., Hong NTT; Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam., Ny NTH; Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam., Anh NT; Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam., Thanh LK; Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam., Phuong HT; Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam., Vy NHT; Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam., Thanh NTL; Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam., Khanh TH; Children's Hospital 1, Ho Chi Minh City, Viet Nam., Hung NT; Children's Hospital 1, Ho Chi Minh City, Viet Nam., Viet DC; Children's Hospital 2, Ho Chi Minh City, Viet Nam., Nam NT; City Children's Hospital, Ho Chi Minh City, Viet Nam., Chau NVV; Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam., van Doorn HR; Oxford University Clinical Research Unit, Hanoi, Viet Nam; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom., Tan LV; Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom., Clapham H; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.
المصدر: Epidemics [Epidemics] 2024 Mar; Vol. 46, pp. 100754. Date of Electronic Publication: 2024 Feb 27.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101484711 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0067 (Electronic) Linking ISSN: 18780067 NLM ISO Abbreviation: Epidemics Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Amsterdam : Elsevier
مواضيع طبية MeSH: Enterovirus* , Hand, Foot and Mouth Disease*/epidemiology , Foot-and-Mouth Disease* , Piperidones* , Benzeneacetamides*, Child ; Infant ; Animals ; Humans ; Child, Preschool ; Vietnam/epidemiology ; Serogroup ; China/epidemiology
مستخلص: Hand, foot and mouth disease (HFMD) is highly prevalent in the Asia Pacific region, particularly in Vietnam. To develop effective interventions and efficient vaccination programs, we inferred the age-time-specific transmission patterns of HFMD serotypes enterovirus A71 (EV-A71), coxsackievirus A6 (CV-A6), coxsackievirus A10 (CV-A10), coxsackievirus A16 (CV-A16) in Ho Chi Minh City, Vietnam from a case data collected during 2013-2018 and a serological survey data collected in 2015 and 2017. We proposed a catalytic model framework with good adaptability to incorporate maternal immunity using various mathematical functions. Our results indicate the high-level transmission of CV-A6 and CV-A10 which is not obvious in the case data, due to the variation of disease severity across serotypes. Our results provide statistical evidence supporting the strong association between severe illness and CV-A6 and EV-A71 infections. The HFMD dynamic pattern presents a cyclical pattern with large outbreaks followed by a decline in subsequent years. Additionally, we identify the age group with highest risk of infection as 1-2 years and emphasise the risk of future outbreaks as over 50% of children aged 6-7 years were estimated to be susceptible to CV-A16 and EV-A71. Our study highlights the importance of multivalent vaccines and active surveillance for different serotypes, supports early vaccination prior to 1 year old, and points out the potential utility for vaccinating children older than 5 years old in Vietnam.
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.)
References: J R Soc Interface. 2018 Sep 12;15(146):. (PMID: 30209044)
Elife. 2023 Jun 09;12:. (PMID: 37294299)
Sci Rep. 2019 Mar 7;9(1):3856. (PMID: 30846756)
Int J Mol Sci. 2019 Oct 20;20(20):. (PMID: 31635198)
Vaccine. 2020 Dec 14;38(52):8273-8285. (PMID: 33223308)
J Infect Dis. 2022 Jan 5;225(1):75-83. (PMID: 32211772)
J R Soc Interface. 2019 Jul 26;16(156):20190207. (PMID: 31362614)
Euro Surveill. 2018 Nov;23(46):. (PMID: 30458911)
Int J Mol Sci. 2022 Dec 22;24(1):. (PMID: 36613612)
Emerg Microbes Infect. 2018 Jan 24;7(1):8. (PMID: 29362406)
Virol J. 2014 Sep 01;11:157. (PMID: 25178398)
J Gen Virol. 2015 May;96(Pt 5):1067-1079. (PMID: 25614593)
Int J Mol Sci. 2019 Mar 13;20(6):. (PMID: 30871133)
PLoS One. 2015 May 26;10(5):e0127999. (PMID: 26011735)
Nat Commun. 2022 Nov 26;13(1):7280. (PMID: 36435844)
J Epidemiol Community Health. 1984 Mar;38(1):85-8. (PMID: 6707569)
Vaccine. 2018 Jun 7;36(24):3445-3452. (PMID: 29739716)
Int J Infect Dis. 2019 Mar;80:1-9. (PMID: 30550944)
Elife. 2020 May 26;9:. (PMID: 32450946)
Lancet Microbe. 2021 Jan;2(1):e41-e47. (PMID: 35544228)
Open Forum Infect Dis. 2019 Jul 1;6(7):. (PMID: 31363772)
N Engl J Med. 2014 Feb 27;370(9):818-28. (PMID: 24571754)
J Clin Virol. 2010 May;48(1):49-54. (PMID: 20189452)
Emerg Microbes Infect. 2018 May 18;7(1):94. (PMID: 29777102)
J Med Virol. 2017 Dec;89(12):2116-2121. (PMID: 28771766)
Emerg Infect Dis. 2020 Feb;26(2):298-306. (PMID: 31961293)
Lancet. 2022 Apr 30;399(10336):1708-1717. (PMID: 35427481)
Elife. 2019 May 23;8:. (PMID: 31120419)
Emerg Infect Dis. 2018 Mar;24(3):. (PMID: 29460747)
Sci Rep. 2017 Jul 20;7(1):6060. (PMID: 28729702)
Heliyon. 2022 Dec 01;8(12):e12042. (PMID: 36478843)
PLoS One. 2011;6(7):e21116. (PMID: 21765891)
BMC Med. 2022 Nov 9;20(1):436. (PMID: 36352415)
J Biomed Sci. 2019 Oct 18;26(1):75. (PMID: 31627753)
Stat Med. 1990 Aug;9(8):953-67. (PMID: 2218197)
PLoS One. 2014 Apr 28;9(4):e96051. (PMID: 24776922)
PLoS One. 2012;7(12):e52432. (PMID: 23300669)
PLoS Negl Trop Dis. 2016 Mar 24;10(3):e0004562. (PMID: 27010319)
Virol J. 2015 Jun 09;12:85. (PMID: 26050791)
Am J Trop Med Hyg. 2011 Jan;84(1):127-34. (PMID: 21212214)
Cutis. 2018 Nov;102(5):353-356. (PMID: 30566537)
Wellcome Open Res. 2019 May 1;4:75. (PMID: 31168485)
Eur J Clin Microbiol Infect Dis. 2018 Mar;37(3):391-398. (PMID: 29411190)
BMC Infect Dis. 2016 Nov 21;16(1):691. (PMID: 27871252)
PLoS Negl Trop Dis. 2018 Feb 9;12(2):e0006246. (PMID: 29425199)
Int J Biometeorol. 2020 Mar;64(3):389-396. (PMID: 31720856)
BMC Infect Dis. 2019 Mar 11;19(1):241. (PMID: 30866853)
J Biomed Sci. 2014 Feb 18;21:16. (PMID: 24548776)
Emerg Infect Dis. 2007 Nov;13(11):1733-41. (PMID: 18217559)
Rev Med Virol. 2020 Mar;30(2):e2087. (PMID: 31811676)
Sci Rep. 2016 Dec 09;6:38874. (PMID: 27934956)
Hum Vaccin Immunother. 2014;10(2):360-7. (PMID: 24231751)
J Med Virol. 2015 Jun;87(6):954-60. (PMID: 25754274)
PLoS Negl Trop Dis. 2020 Aug 17;14(8):e0008544. (PMID: 32804980)
Med Microbiol Immunol. 2016 Oct;205(5):397-407. (PMID: 27406374)
Clin Microbiol Infect. 2012 May;18(5):E110-8. (PMID: 22404077)
J Stat Softw. 2017;76:. (PMID: 36568334)
Front Microbiol. 2016 Mar 30;7:391. (PMID: 27065963)
J Clin Virol. 2019 Jan;110:1-6. (PMID: 30472520)
Health Place. 2015 Sep;35:147-54. (PMID: 26402922)
Lancet. 2013 Jun 8;381(9882):2024-32. (PMID: 23726161)
N Engl J Med. 2014 Feb 27;370(9):829-37. (PMID: 24571755)
PLoS Negl Trop Dis. 2020 Mar 3;14(3):e0008124. (PMID: 32126083)
فهرسة مساهمة: Keywords: Catalytic model; Force of infection; Hand, foot and mouth disease; Serological data
المشرفين على المادة: 16VY3TM7ZO (antineoplaston A10)
0 (Piperidones)
0 (Benzeneacetamides)
تواريخ الأحداث: Date Created: 20240301 Date Completed: 20240312 Latest Revision: 20240320
رمز التحديث: 20240320
مُعرف محوري في PubMed: PMC10945305
DOI: 10.1016/j.epidem.2024.100754
PMID: 38428358
قاعدة البيانات: MEDLINE
كن أول من يترك تعليقا!
يجب تسجيل دخولك أولا